SEC Form 4 · accession 0001271214-15-000005
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Stambaugh
Officer — VP, Clinical and Reimbursement
Period of report
Jan 21, 2015
Accepted (ET)
Jan 23, 2015 · 5:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $21.06 | Jan 21, 2015 | A | 25,000 | A | — | Jan 20, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F112.5% of the shares subject to the option shall vest on July 1, 2015 and 1/48th of the shares subject to the option shall vest monthly thereafter.